Official clinic pages and public records where available.
Public source checks
The rows below standardise what was and was not confirmed from the reviewed public sources.
How to read these checks: ✓ Confirmed · ◐ Partial · — Not confirmed
Comparison checklist
How to read this checklist: ✓ Yes · ◐ Partial · — Not confirmed
Identity and regulatory checks
The links below are neutral reference points, not approval signals. They show what could be confirmed directly from the clinic’s own public pages at review time.
HUM2N’s public trail is strongest on location and service framing. The homepage and IV Lab page show a London longevity clinic with a discovery-call process, a HUM2N Life Assessment step, and a Chelsea location trail at 35 Ixworth Pl, London SW3 3QX. No named clinician was clearly confirmed from the reviewed public pages.
What this profile still does not establish is a direct regulator or legal-entity match. No confirmed Companies House record, CQC provider page, GMC register profile, or named GPhC dispensing route was safely matched from the reviewed public trail, so the Ixworth Place address should still be read as a strong clinic contact trail rather than a fully regulator-linked verification chain.
- Official homepage ↗ — public page reviewed for the peptide service description
- IV Lab page ↗ — reviewed for named clinician trail
- Official contact page ↗ — reviewed for Ixworth Place address, phone, and email
- Homepage ↗ — reviewed for MedicalClinic schema and wider clinic identity
This record is publishable and materially stronger than a bare minimal-reference listing, but legal-entity and regulator checks should stay open until stronger public evidence appears. See our methodology for record status definitions.
Public address trail reviewed: 35 Ixworth Pl, London SW3 3QX
The public trail supports a postcode-area marker rather than a clinic-entrance confirmation.
Please confirm the address before visiting.
Questions to ask before booking
Because HUM2N’s public trail is stronger on longevity and IV service framing than on detailed clinical disclosure, these questions are worth asking directly:
- Who is the named medical lead for the service you want?
- What does the HUM2N Life Assessment include before treatment is recommended?
- Which services are actually provided at 35 Ixworth Pl, and which are handled remotely?
- How are side effects, review intervals, and stopping criteria handled in practice?
- Which pharmacy or supplier, if any, is used for prescribed products?
- Can the clinic point you to a direct regulator or company record for the operating entity?